de Vries ST - Search Results

1

Views on the Development and Use of a New Digital Adverse Drug Event Reporting Platform in Australia: A Qualitative Study.

Gebreyohannes EA, Thornton C, Thiessen M, de Vries ST, Coombs G, Hwang I, Lim R. Gebreyohannes EA, et al. Among authors: de vries st. Drug Saf. 2024 Nov 2. doi: 10.1007/s40264-024-01489-3. Online ahead of print. Drug Saf. 2024. PMID: 39487335

2

Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.

de Vries ST, Mol PG, de Zeeuw D, Haaijer-Ruskamp FM, Denig P. de Vries ST, et al. Among authors: de zeeuw d. Drug Saf. 2013 Sep;36(9):765-77. doi: 10.1007/s40264-013-0036-8. Drug Saf. 2013. PMID: 23553447 Clinical Trial.

3

Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study.

de Vries ST, Wong L, Sutcliffe A, Houÿez F, Ruiz CL, Mol PG; IMI Web-RADR Work Package 3b Consortium. de Vries ST, et al. Drug Saf. 2017 May;40(5):443-455. doi: 10.1007/s40264-016-0494-x. Drug Saf. 2017. PMID: 28035492 Free PMC article.

4

Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study.

de Vries ST, Harrison J, Revelle P, Ptaszynska-Neophytou A, Radecka A, Ragunathan G, Tregunno P, Denig P, Mol PGM. de Vries ST, et al. Drug Saf. 2019 Jul;42(7):881-886. doi: 10.1007/s40264-019-00800-x. Drug Saf. 2019. PMID: 30725337 Free PMC article.

5

Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care.

Denig P, van Puijenbroek EP, Soliman N, Mol PGM, de Vries ST. Denig P, et al. Among authors: de vries st. Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1175-1179. doi: 10.1002/pds.4839. Epub 2019 Jun 17. Pharmacoepidemiol Drug Saf. 2019. PMID: 31209934 Free PMC article.

6

Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a Questionnaire.

Schreuder N, de Hoog Q, de Vries ST, Jager PL, Kosterink JGW, van Puijenbroek EP. Schreuder N, et al. Among authors: de vries st, de hoog q. Drug Saf. 2020 Apr;43(4):319-328. doi: 10.1007/s40264-019-00895-2. Drug Saf. 2020. PMID: 31916082 Free PMC article.

7

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study.

de Vries ST, Denig P, Ekhart C, Mol PGM, van Puijenbroek EP. de Vries ST, et al. Drug Saf. 2020 May;43(5):489-495. doi: 10.1007/s40264-020-00913-8. Drug Saf. 2020. PMID: 32048185 Free PMC article.

8

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.

de Vries ST, Denig P, Andrić A, Dimov Di Giusti M, Ptaszynska-Neophytou A, Härmark L, Mol PGM; IMI Web-RADR Work Package 3b Consortium and SCOPE Joint Action Work Package 4. de Vries ST, et al. Drug Saf. 2021 Oct;44(10):1073-1083. doi: 10.1007/s40264-021-01098-4. Epub 2021 Aug 8. Drug Saf. 2021. PMID: 34368940 Free PMC article.

9

What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study.

Roldan Munoz S, Postmus D, de Vries ST, Gross-Martirosyan L, Bahri P, Hillege H, Mol PGM. Roldan Munoz S, et al. Among authors: de vries st. Drug Saf. 2023 Mar;46(3):243-255. doi: 10.1007/s40264-022-01270-4. Epub 2023 Feb 15. Drug Saf. 2023. PMID: 36790560 Free PMC article.

10

The validity of a patient-reported adverse drug event questionnaire using different recall periods.

de Vries ST, Haaijer-Ruskamp FM, de Zeeuw D, Denig P. de Vries ST, et al. Among authors: de zeeuw d. Qual Life Res. 2014 Nov;23(9):2439-45. doi: 10.1007/s11136-014-0715-7. Epub 2014 May 22. Qual Life Res. 2014. PMID: 24848596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters